MyAverix Finance
HK · Healthcare
Shanghai Bio-heart Biological (2185)
Biotechnology
Shanghai Bio-heart Biological (2185) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $851.96M, P/E ratio is 18.00, net margin is -155.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2185
Shanghai Bio-heart Biological (2185) — FAQ
What is Shanghai Bio-heart Biological's market cap?
Shanghai Bio-heart Biological (2185) has a reported market cap of $851.96M (data as of 2026-05-21).
What is 2185's P/E ratio?
The price-to-earnings (P/E) ratio for Shanghai Bio-heart Biological (2185) is 18.00 (data as of 2026-05-21).
Does Shanghai Bio-heart Biological pay a dividend?
Dividend yield is not available in the current snapshot for Shanghai Bio-heart Biological (2185). Check the MyAverix Finance app for the latest dividend data.
What sector is Shanghai Bio-heart Biological in?
Shanghai Bio-heart Biological (2185) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2185 listed on?
2185 is listed on HK.
What is Shanghai Bio-heart Biological's net margin?
Shanghai Bio-heart Biological (2185) reports a net margin of -155.9% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.